Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPX-115 in Partial-thickness Rotator Cuff Tear
NCT07219654Phase 2Recruiting
- Sponsor
- Tego Science
- Start
- Jun 2026
- Primary completion
- May 2027
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of TPX-115 in partial-thickness rotator cuff tear (PRCT), sponsored by Tego Science. Started Jun 2026; status: recruiting.
02
Drugs
TPX-115
03
Conditions
partial-thickness rotator cuff tear (PRCT)
Beyond the preview
Go deeper on NCT07219654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07219654.